Kasprzak K S, Ward J M, Poirier L A, Reichardt D A, Denn A C, Reynolds C W
Carcinogenesis. 1987 Jul;8(7):1005-11. doi: 10.1093/carcin/8.7.1005.
The effects of magnesium carbonate (MgCarb) on carcinogenesis and natural killer (NK) cell modulation by nickel subsulfide (Ni3S2) were studied. Male Fischer F344/NCr rats, 50-90 g body wt, 20 rats per group, received single i.m. injections into both thigh muscles of 2.5 mg Ni3S2 alone or combined with different proportions of MgCarb; the Mg/Ni molar ratio ranged from 0.25 to 4.0. Control rats received i.m. injections of normal saline or magnesium acetate (MgAcet), or s.c. MgCarb at a site distant from Ni3S2. The animals were observed over 79 weeks for the development of tumors. The NK cell activity was determined over the first 3 weeks of the experiment in separate groups of rats treated as above, with the use of the 51Cr/YAC-1 release assay for blood and spleen cells and the peroxidase localization of Ox-8-immunoreactive lymphocytes at the injection site. I.m. administration of MgCarb mixed with Ni3S2 up to the Mg/Ni molar ratio of 1.0 inhibited the carcinogenicity of Ni3S2 in a dose-related manner; final incidence of sarcomas decreased from 100 to 55% and the appearance of first tumors was delayed from 25 to 39 weeks. Higher doses of MgCarb did not exert further effect. Distant s.c. injection of MgCarb or local i.m. application of MgAcet did not change the carcinogenic potency of i.m. Ni3S2. MgCarb or saline alone did not produce any tumors. I.m. Ni3S2 had no significant influence on the activity of NK cells in blood and spleen, while i.m. MgCarb alone did not affect the NK activity in blood but doubled it transiently in the spleen 24 h after injection. In the injected muscle, Ox-8-positive cells became abundant around MgCarb but could not be found close to Ni3S2. This inhibitory effect of Ni3S2 was partially reversed by MgCarb. Also, numerous multinucleated giant cells infiltrated the sites of injection of MgCarb alone and MgCarb + Ni3S2 but not Ni3S2 alone. The results indicate a dose-dependent and strictly local character of the inhibition by MgCarb of Ni3S2 carcinogenesis, as well as a possible involvement of NK and phagocytic cells in this inhibition.
研究了碳酸镁(MgCarb)对硫化镍(Ni3S2)致癌作用及自然杀伤(NK)细胞调节的影响。选用体重50 - 90克的雄性Fischer F344/NCr大鼠,每组20只,分别于双侧大腿肌肉单次肌内注射2.5毫克单独的Ni3S2或与不同比例的MgCarb混合;Mg/Ni摩尔比范围为0.25至4.0。对照大鼠肌内注射生理盐水或醋酸镁(MgAcet),或在远离Ni3S2的部位皮下注射MgCarb。观察动物79周以监测肿瘤发生情况。在实验的前3周,对上述分组处理的大鼠分别测定NK细胞活性,采用51Cr/YAC - 1释放试验检测血液和脾脏细胞,以及通过过氧化物酶定位检测注射部位的Ox - 8免疫反应性淋巴细胞。肌内注射与Ni3S2混合的MgCarb直至Mg/Ni摩尔比为1.0时,以剂量相关方式抑制了Ni3S2的致癌性;肉瘤的最终发生率从100%降至55%,首个肿瘤的出现时间从25周延迟至39周。更高剂量的MgCarb未产生进一步影响。皮下远距离注射MgCarb或局部肌内应用MgAcet均未改变肌内注射Ni3S2的致癌效力。单独的MgCarb或生理盐水未产生任何肿瘤。肌内注射Ni3S2对血液和脾脏中NK细胞活性无显著影响,而单独肌内注射MgCarb对血液中的NK活性无影响,但注射后24小时可使脾脏中的NK活性暂时加倍。在注射的肌肉中,MgCarb周围的Ox - 8阳性细胞增多,但在Ni3S2附近未发现。MgCarb部分逆转了Ni3S2的这种抑制作用。此外,大量多核巨细胞浸润单独注射MgCarb以及MgCarb + Ni3S2的注射部位,但不浸润单独注射Ni3S2的部位。结果表明,MgCarb对Ni3S2致癌作用的抑制具有剂量依赖性和严格的局部特征,以及NK细胞和吞噬细胞可能参与了这种抑制作用。